Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,611.20
(
0.27%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
93.55
(
-2.53%
)
Bitcoin
70,645.63
(
-1.01%
)
News Focus
News Focus
Post# of 828657
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dstock07734

Send PM Follow Ignore
Followers 76
Posts 6477
Boards Moderated 0
Alias Born 05/25/2021

dstock07734

Re: meirluc post# 659039

Monday, 12/25/2023 1:31:44 PM

Monday, December 25, 2023 1:31:44 PM

Post# of 828657

If utilization of poly ICLC with DCVax-L substantially reduces the need to
include a CI in the mix



I have doubt about this statement. As a matter of fact, adding pd-1 inhibitor to the combination of DCVax-L + poly-iclc trigger antitumor immune response so intense that patients had to go through surgery and take immune-suppressive drug. Recall the patient #5 from Dr. Liau's presentation?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News